Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Breeze Clear is a specific Chinese herbal medicine (CHM) formulation evaluated by Taichung Veterans General Hospital as an adjuvant therapy for chronic rhinosinusitis (CRS). Administered via nasal irrigation following functional endoscopic sinus surgery (FESS), the treatment aims to enhance postoperative healing, reduce mucosal inflammation, and improve clinical outcomes compared to standard saline irrigation. The formulation is provided in a powder form, which is reconstituted into a solution for irrigation. It leverages the synergistic effects of multiple traditional herbal components known for their anti-inflammatory and antimicrobial properties to alleviate symptoms such as nasal congestion and discharge while promoting mucociliary clearance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Breeze Clear.